Cargando…
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
BACKGROUND: Standard treatment for unresectable esophageal squamous cell carcinoma (ESCC) without distant metastasis is definitive chemoradiotherapy (dCRT), in which the incidence of esophageal fistula (EF) is reported to be 10–12%. An ad hoc analysis of JCOG0303, a phase II/III trial of dCRT for pa...
Autores principales: | Kawakami, Takeshi, Tsushima, Takahiro, Omae, Katsuhiro, Ogawa, Hirofumi, Shirasu, Hiromichi, Kito, Yosuke, Yoshida, Yukio, Hamauchi, Satoshi, Todaka, Akiko, Machida, Nozomu, Yokota, Tomoya, Yamazaki, Kentaro, Fukutomi, Akira, Onozawa, Yusuke, Yasui, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960135/ https://www.ncbi.nlm.nih.gov/pubmed/29776344 http://dx.doi.org/10.1186/s12885-018-4486-3 |
Ejemplares similares
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
por: Inoue, Hiroto, et al.
Publicado: (2021) -
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study
por: Kawai, Sadayuki, et al.
Publicado: (2017) -
Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
por: Shirasu, Hiromichi, et al.
Publicado: (2020) -
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
por: Kawakami, Takeshi, et al.
Publicado: (2023) -
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study
por: Taniguchi, Hiroya, et al.
Publicado: (2023)